FOR IMMEDIATE RELEASE BioPort 2018 Announces Keynote Speakers  And Explores the Future of Life Sciences in Atlantic Canada June 21, 2018 – Halifax, NOVA SCOTIA – Health and life sciences innovators, industry leaders, and investors from across North America will come together to attend BioPort 2018, on November 7-8, 2018 at the Halifax Convention Centre. This year’s…

See original article here by Jennifer Lee | Jun 24, 2018 The keynote speakers for the 2018 BioPort conference will be Corrina Lathan, CEO of AnthroTronix in Maryland, and William Charnetski, Ontario’s Chief Health Innovation Strategist.BioNova, which organizes the annual gathering for life science innovators, industry leaders, and investors from across North America, revealed the keynote speakers in a statement last week. BioPort will…

(Halifax, 21 June 2018) – Each year EY recognizes entrepreneurs who drive growth, live outside the box and disrupt with purpose. Today, the firm has named 33 finalists across 8 categories in its EY Entrepreneur Of The Year® Awards 2018 Atlantic program. “Atlantic Canada has always owned a unique identity, but we’re beginning to see the…

For the first time in the 34 years of the Annual Nova Scotia Export Achievement Awards, two companies were chosen as Nova Scotia Exporters of the Year at ceremonies Tuesday in Halifax. Spring Loaded Technology of Dartmouth was named the Exporter of the Year for exports of less than $5 million, and Tony’s Meats received…

Vice President of Investment Innovacorp is Nova Scotia’s early stage venture capital organization. It works to find, fund and foster innovative Nova Scotia start-ups that strive to change the world. The goal is to help those start-ups commercialize their technologies and succeed in the global marketplace. Target industries include information technology, life sciences, clean technology…

See original postings and apply here

See original story here HALIFAX, Nova Scotia, May 31, 2018 (GLOBE NEWSWIRE) — IMV Inc. (“IMV” or the “Corporation”) (TSX:IMV) (OTCQX:IMMVD), a clinical stage immunotherapy company, today announced that its common shares have been approved for listing on the Nasdaq Capital Marketunder the symbol “IMV.” Trading will commence as early as Friday, June 1, 2018. The Corporation will retain its listing…

2015 © Copyright - Bionova